ArticleClinical and vaccine immunology : CVI2011

Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.

Tansi Khodai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.